RBC Capital raised the firm’s price target on Hologic (HOLX) to $89 from $86 and keeps a Sector Perform rating on the shares after its Q4 ...
For full-year 2024, R. STAHL continues to expect an increase in sales to between € 335 million and € 350 million. The company has specified its forecast for EBITDA pre exceptionals at between € 35 ...